Hygen Pharmaceuticals Inc.
Redmond, WA
- UEI
- QKBMULYZTKM5
- CAGE
- 56W96
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 8635 154th Ave NE, Redmond, WA 98052, USA
- Website
- hygenpharma.com
- Founded
- 1993
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 51 Wholesale Trade – Nondurable Goods
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $228,319 |
| FY2025 | $428,332 |
| FY2024 | $414,596 |
| FY2023 | $433,014 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $228,319 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| PBA Health | Kansas City, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Woods International LLC | Riverview, FL | 622110 General Medical and Surgical Hospitals |
| Low Cost RX LLC | Westland, MI | 456110 Pharmacies and Drug Retailers |
| Honolulu | Waipahu, HI | 541611 Administrative Management and General Management Consulting Services |
| Tri-Pharma, Inc. | Kennesaw, GA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Hygen Pharmaceuticals Inc., a minority-owned, 8(a)-certified small disadvantaged business based in Redmond, Washington, supplies prescription and specialty pharmaceuticals exclusively to the Department of Veterans Affairs as a prime contractor under total small business set-asides and full-and-open competitions. The company operates as a Subchapter S corporation and is Subcontinent Asian American-owned. All 125 recent federal awards are prime contracts; the vendor does not subcontract on federal work.
Hygen's capability portfolio is narrowly focused on pharmaceutical distribution to VA Consolidated Mail Outpatient Pharmacies (CMOPs) nationwide. Representative work includes a $130.9 thousand firm-fixed-price purchase order (August 2024) from VISN 22 for Sumatriptan Injection Syringe delivery to Tucson CMOP; a $178.4 thousand order (November 2023) from VISN 15 for Dorzolamide/Timolol ophthalmic solution to seven VA CMOP locations; a $213 thousand order (April 2022) from VISN 15 for multi-line pharmaceutical products (thyroid medications, acamprosate tablets, dextrose solutions, ophthalmic solutions) to CMOP locations; and recurring smaller orders (typically $5 thousand to $75 thousand) for individual pharmaceutical line items including propranolol, sertraline, ferrous sulfate, acetaminophen/butalbital/caffeine combinations, and various controlled substances. All awards are classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC Drugs and Biologicals.
Customer concentration sits almost entirely within the VA's VISN network. The top five VISNs account for 92% of awards by count and 95% of combined potential value. VISN 15 dominates across both metrics — 61 awards carrying $3.3 million combined potential value — followed by VISN 22 (16 awards, $906 thousand), VISN 7 (15 awards, $692 thousand), VISN 12 (14 awards, $539 thousand), and VISN 1 (9 awards, $290 thousand). The company has served seven distinct federal agencies total, but non-VA work is negligible. Awards are individual purchase orders with performance periods typically spanning one to three months; there are no parent contract vehicles, IDIQs, GWACs, or BPAs in the footprint.
Activity has been volatile but persistent. The vendor received 5 awards in 2022, 12 in 2023, 5 in 2024, 12 in 2025, and 4 so far in 2026 (through early September). Combined potential value across all 125 awards is $6.1 million, with $6.1 million obligated, indicating execution-to-ceiling at or near 100% across the portfolio. Only one award carries an ultimate completion date within the next twenty-four months ($47 thousand combined potential value), signaling minimal near-term recompete exposure. The company's 8(a) certification expired March 9, 2025, as noted in one source narrative; recent awards from September and August 2026 do not flag expiration status, but this status change warrants verification for bid-eligibility and set-aside posture going forward.
SBA capabilities narrative
HyGen Pharmaceuticals, Inc. is a nationwide wholesale distributor of Prescription Pharmaceuticals both generic and brand-name drugs, OTC Drugs and Diabetic Medical Supplies.
23 years of experience in the commercial business sector of pharmaceutical products to independently owned retail-pharmacies, Long-term Care facilities, and small Chain-Pharmacies.
Highest quality, competitive pricing and superior service.
Quick answers
Is Hygen Pharmaceuticals Inc. registered in SAM.gov?
Yes. Hygen Pharmaceuticals Inc.'s SAM.gov registration is active through October 27, 2026.
How much has Hygen Pharmaceuticals Inc. received in federal contracts?
Federal contracts obligated $428,332 to Hygen Pharmaceuticals Inc. in fiscal year 2025 and $1,504,260 in fiscal years 2023 through 2027.
How does Hygen Pharmaceuticals Inc. rank among federal contractors?
Hygen Pharmaceuticals Inc. ranked #100 in NAICS 325412 in FY2025.
What is Hygen Pharmaceuticals Inc.'s most recent federal award?
Hygen Pharmaceuticals Inc.'s most recent federal contract award is Propranolol 80MG for tucson cmop (36C77026P0118), from Veterans Integrated Service Network 15 (VHA), on September 3, 2026.
On GovTribe
See Hygen Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors